Skip to main content

Table 3 Results of prior HR-HPV testing alone

From: Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs

HPV test method CIN1 (n = 713) CIN2/3 (n = 906) ICC (n = 220)
Negative (%) Positive (%) Negative (%) Positive (%) Negative (%) Positive (%)
HC2 test 46 (14.9) 263 (85.1) 23 (4.6) 476 (95.4) 4 (5.8) 65 (94.2)
Genotyping 97 (24.0) 307 (76.0) 19 (4.7) 388 (95.3) 12 (7.9) 139 (92.1)
Total 143 (20.1) 570 (79.9) 42 (4.6) 864 (95.4) 16 (7.3) 204 (92.7)
  1. HR-HPV high-risk human papillomavirus, CIN cervical intraepithelial neoplasia, ICC invasive cervical cancer, HC2 Hybrid Capture 2